Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Krystexxa
Pharma
Amid buzz for Amgen's obesity drug, company sees revenue boost
The buzz about Amgen’s obesity pipeline overshadowed the company’s solid work on the top line as revenue came in at $7.4 billion for a 22% increase.
Kevin Dunleavy
May 3, 2024 9:05am
Amgen settles with FTC over its $28B Horizon buyout
Sep 1, 2023 10:03am
Amgen fights FTC's request for injunction against Horizon buyout
Aug 24, 2023 11:12am
Amgen will delay buyout of Horizon, complying with FTC request
May 19, 2023 11:05am
FTC move on Amgen-Horizon doesn't doom Pfizer-Seagen: analysts
May 17, 2023 11:04am
Amgen's new buy Horizon post falling first-quarter Tepezza sales
May 3, 2023 11:32am
